Ausgabe 2/2015
Inhalt (22 Artikel)
Comprehensive review of the detection methods for synthetic cannabinoids and cathinones
Akira Namera, Maho Kawamura, Akihiro Nakamoto, Takeshi Saito, Masataka Nagao
AH-7921: the list of new psychoactive opioids is expanded
Maria Katselou, Ioannis Papoutsis, Panagiota Nikolaou, Chara Spiliopoulou, Sotiris Athanaselis
Quantification of methylone and metabolites in rat and human plasma by liquid chromatography-tandem mass spectrometry
Kayla N. Ellefsen, Marta Concheiro, Masaki Suzuki, Kenner C. Rice, Joshua S. Elmore, Michael H. Baumann, Marilyn A. Huestis
Identification and quantitation of 5-fluoro-ADB-PINACA and MAB-CHMINACA in dubious herbal products
Amin Wurita, Koutaro Hasegawa, Kayoko Minakata, Kunio Gonmori, Hideki Nozawa, Itaru Yamagishi, Kanako Watanabe, Osamu Suzuki
Simultaneous quantification of 37 synthetic cannabinoid metabolites in human urine by liquid chromatography-tandem mass spectrometry
Moonhee Jang, Ilchung Shin, Jihyun Kim, Wonkyung Yang
Simultaneous plasma and oral fluid morphine and codeine concentrations after controlled administration of poppy seeds with known opiate content
Matthew N. Newmeyer, Marta Concheiro, Jose Luiz da Costa, Charles LoDico, David A. Gorelick, Marilyn A. Huestis
A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products
Nahoko Uchiyama, Yoshihiko Shimokawa, Ruri Kikura-Hanajiri, Yosuke Demizu, Yukihiro Goda, Takashi Hakamatsuka
Cannabinoid disposition in oral fluid after controlled vaporizer administration with and without alcohol
Rebecca L. Hartman, Sébastien Anizan, Moonhee Jang, Timothy L. Brown, Keming Yun, David A. Gorelick, Gary Milavetz, Andrew Spurgin, Gary Gaffney, Marilyn A. Huestis
Urinary excretion and metabolism of the α-pyrrolidinophenone designer drug 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one (PV9) in humans
Noriaki Shima, Hidenao Kakehashi, Shuntaro Matsuta, Hiroe Kamata, Shihoko Nakano, Keiko Sasaki, Tooru Kamata, Hiroshi Nishioka, Kei Zaitsu, Takako Sato, Akihiro Miki, Munehiro Katagi, Hitoshi Tsuchihashi
Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry
Marisol S. Castaneto, Ariane Wohlfarth, Shaokun Pang, Mingshe Zhu, Karl B. Scheidweiler, Robert Kronstrand, Marilyn A. Huestis
Identification of analogs of LY2183240 and the LY2183240 2′-isomer in herbal products
Akiko Asada, Takahiro Doi, Akihiro Takeda, Takaomi Tagami, Masami Kawaguchi, Yuka Satsuki, Yoshiyuki Sawabe
Development and validation of a liquid chromatography–mass spectrometry procedure after solid-phase extraction for detection of 19 doping peptides in human urine
Monica Mazzarino, Valeria Calvaresi, Xavier de la Torre, Graziella Parrotta, Chiara Sebastianelli, Francesco Botrè
Differentiation of regioisomeric chloroamphetamine analogs using gas chromatography–chemical ionization-tandem mass spectrometry
Shoko Negishi, Yukiko Nakazono, Yuko T. Iwata, Tatsuyuki Kanamori, Kenji Tsujikawa, Kenji Kuwayama, Tadashi Yamamuro, Kazuna Miyamoto, Takuya Yamashita, Fumiyo Kasuya, Hiroyuki Inoue
Identification and quantification of 4′-methoxy-α-pyrrolidinobutiophenone (4-MeOPBP) in human plasma and urine using LC–TOF-MS in an autopsy case
Kaori Shintani-Ishida, Mami Nakamura, Misa Tojo, Nozomi Idota, Hiroshi Ikegaya
Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues
Samuel D. Banister, Jordyn Stuart, Trent Conroy, Mitchell Longworth, Madhura Manohar, Corinne Beinat, Shane M. Wilkinson, Richard C. Kevin, David E. Hibbs, Michelle Glass, Mark Connor, Iain S. McGregor, Michael Kassiou
A new pyrazole-carboxamide type synthetic cannabinoid AB-CHFUPYCA [N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide] identified in illegal products
Nahoko Uchiyama, Kazuhiro Asakawa, Ruri Kikura-Hanajiri, Taizo Tsutsumi, Takashi Hakamatsuka
Evaluation of the neurochemical effects of methoxetamine using brain microdialysis in mice
Yuki Fuchigami, Xunsing Fu, Rie Ikeda, Shigeru Kawakami, Mitsuhiro Wada, Ruri Kikura-Hanajiri, Naotaka Kuroda, Kenichiro Nakashima
Postmortem distribution of MAB-CHMINACA in body fluids and solid tissues of a human cadaver
Koutaro Hasegawa, Amin Wurita, Kayoko Minakata, Kunio Gonmori, Hideki Nozawa, Itaru Yamagishi, Kanako Watanabe, Osamu Suzuki
Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites
Laura M. Huppertz, Philippe Bisel, Folker Westphal, Florian Franz, Volker Auwärter, Bjoern Moosmann
A case of fatal intoxication due to the new designer drug 25B-NBOMe
Ken-ichi Yoshida, Kanju Saka, Kaori Shintani-Ishida, Hideyuki Maeda, Makoto Nakajima, Shu-ichi Hara, Masahide Ueno, Katsunori Sasaki, Hirotaro Iwase, Tetsuya Sakamoto
Diphenidine and its metabolites in blood and urine analyzed by MALDI-Q-TOF mass spectrometry
Kayoko Minakata, Itaru Yamagishi, Hideki Nozawa, Koutaro Hasegawa, Amin Wurita, Kunio Gonmori, Masako Suzuki, Kanako Watanabe, Osamu Suzuki
Identification and quantitation of mifepristone and its N-demethyl metabolite in the plasma of an aborted fetus by liquid chromatography–quadrupole–time-of-flight–mass spectrometry (LC–Q–TOFMS) and ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS–MS)
Akira Ishii, Kei Zaitsu, Maiko Kusano, Tomomi Asano, Tadashi Ogawa, Hideki Hattori, Hiroshi Seno